跳至主要内容
临床试验/NCT06181942
NCT06181942招募中不适用

A Real-World Study to Evaluate the Clinical Performance and Safety of da Vinci SP Surgical System for Single-Port Urological Surgeries

Ruijin Hospital1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2023年2月22日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
15
试验地点
1
主要终点
Intraoperative conversion rate

研究概览

简要总结

Study name:A Real-World Study to Evaluate the Clinical Performance and Safety of da Vinci SP Surgical System for Single-Port Urological Surgeries;

Study purpose:This clinical trial is a real-world study to evaluate the clinical performance and safety of da Vinci SP Surgical System ("SP single-port robot" for short) for single-port urological robotic surgeries in the real world, providing a real world evidence for clinical application of the product in the Chinese population.

Study design:Retrospective + prospective, real-world study

Investigational medical device: English name: da Vinci SP Surgical System Model and specification: SP1098 Manufacturer: Intuitive Surgical, Inc.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • Subjects should meet all the following criteria:
  • Subjects who have received or plan to receive RP, PN, RN, radical resection of the renal pelvic carcinoma (one position), pyeloplasty and other single-port urological robotic surgeries with the SP single-port robot;
  • Patients who voluntarily decide to participate in the study and sign the ICF (or exempt from signature of the ICF as approved by the EC).

排除标准

  • The subjects meeting any of the following criteria should be excluded.
  • Patients with missing data on the primary endpoint in retrospective cases;
  • Subjects having any contraindications of single-port robot surgery;
  • The intraoperative anatomy determined that minimally invasive surgery was not suitable;
  • Patients who are considered inappropriate to participate in this Study by investigators.

结局指标

主要结局

Intraoperative conversion rate

时间窗: Intraoperative

incidence of device-related or likely related complications

时间窗: 30 days

次要结局

  • Urethral catheter indwelling duration(up to 4 weeks)
  • Intraoperative bleeding volume(Intraoperative)
  • The rate of intraoperative blood transfusion(Intraoperative)
  • Admission to ICU and ICU LOS(up to 4 weeks)
  • Short-term recovery of functions for1 )Erectile function and 2)Urinary continence function(in the follow-up 1 month after the surgery)
  • Postoperative pain score(follow-ups 1 day (24±4 hours), 3 days (72±4 hours) and 1 month (30±5 days) after the surgery.)
  • Surgical duration(Intraoperative)
  • Length of stay (LOS)(up to 4 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Danfeng Xu

Pro.Danfeng Xu

Ruijin Hospital

研究点 (1)

Loading locations...

相似试验